New drug shows promise for Hard-to-Treat Graves' disease
NCT ID NCT05907668
First seen Feb 02, 2026 · Last updated May 08, 2026 · Updated 21 times
Summary
This study tested a drug called batoclimab in 35 adults with Graves' disease whose thyroid levels remained high despite standard antithyroid medications. The goal was to see if 24 weeks of treatment could bring thyroid hormones back to normal or below normal without increasing the dose of their current medication. The study was completed and focused on safety and effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAVES DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site Number - 6505
Mainz, 55131, Germany
Conditions
Explore the condition pages connected to this study.